John C. McKew's Net Worth
$185 Thousand
Who is John C. McKew?
John C. McKew does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include aTYR PHARMA INC, and LUMOS PHARMA, INC..
SEC CIK
John C. McKew's CIK is 0001640560
Past Insider Trading and Trends
2015 was John C. McKew's most active year for acquiring shares with 3 total transactions. John C. McKew's most active month to acquire stocks was the month of January. 2022 was John C. McKew's most active year for disposing of shares, totalling 6 transactions. John C. McKew's most active month to dispose stocks was the month of March. 2022 saw John C. McKew paying a total of $15,030.00 for 15,500 shares, this is the most they've acquired in one year. In 2022 John C. McKew cashed out on 8,519 shares for a total of $70,918.12, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
aTYR PHARMA INC (LIFE) No price found
VP, Research
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
LUMOS PHARMA, INC. (LUMO) Snapshot price: $3.7
Chief Scientific OfficerJohn C. McKew owns 17,153 units of Common Stock which is worth $63,466.10. From 2020 to 2024 John C. McKew acquired a total of 39,578 shares in LUMOS PHARMA, INC. at a cost of $27,750.00, John also disposed a total of 24,718 shares of LUMOS PHARMA, INC. equalling to $149,231.29.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -6.79% | -1.25K |
$2.82 | -$3,406.09 | 17.15K |
Scheduled
|
Apr 1 - Apr 3
| ||
Form 4
| -2.32% | -438.00 |
$3.03 | -$1,328.02 | 18.4K |
Scheduled
|
Feb 6
| ||
Form 4
| -1.91% | -366.00 |
$3.01 | -$1,101.66 | 18.84K |
Feb 1
| |||
Form 4
| -21.09% | -5.00K |
$3.23 | -$16,144.47 | 18.71K |
Aug 1 - Aug 2
| |||
Form 4
| -12.28% | -3.25K |
$3.28 | -$10,668.94 | 23.21K |
Apr 1 - Apr 4
| |||
Form 4
| +5.40% | 1.35K |
$3.53 | $4,765.21 | 26.46K |
Scheduled
|
Feb 1 - Feb 2
| ||
Form 4
| -16.89% | -5.00K |
$8.13 | -$40,645.58 | 24.6K |
Scheduled
|
Aug 1 - Aug 2
| ||
Form 4
| -0.58% | -169.00 |
$7.62 | -$1,287.78 | 29.1K |
Scheduled
|
Jun 6
| ||
Form 4
| -9.99% | -3.25K |
$8.61 | -$27,982.76 | 29.27K |
Scheduled
|
Apr 1 - Apr 5
| ||
Form 4
| +4.50% | 1.4K |
$10.02 | $14,028.00 | 32.52K |
Feb 1
| |||
Form 4
| -6.66% | -2.21K |
$11.30 | -$25,018.20 | 31.01K |
Scheduled
|
Sep 8
| ||
Form 4
| +151.22% | 20K |
—
|
—
| 33.23K |
Aug 1
| |||
Form 4
| -7.26% | -1.04K |
$12.25 | -$12,691.00 | 13.23K |
Apr 1
| |||
Form 4
| +8.18% | 1.08K |
—
|
—
| 14.26K |
Feb 1
| |||
Form 4
|
∞
| 13K |
—
|
—
| 13K |
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||